Ophthalmology

Promoting Tie2 signaling activity may complement inhibition of VEGF in addressing pathology in disease states characterized by angiogenesis, vascular permeability, and inflammation.

A poll for ophthalmologists and retina specialists to celebrate UV Safety Month. This poll will close July 28, 2021.

Trial shows treatment has acceptable safety profile, may improve visual function.

AAO develops task forces to evaluate academy, review outcomes in ophthalmology.

In order to benchmark 20/20 vision in an infant, the testing types and acuity being measured need to be altered.

Physicians should hospitalize ON patients to prevent blindness, possible death.

Knowledge of tools used in data interpretation helps clinicians trust accuracy of findings.

Structural photoreceptor abnormalities and an area of central sparing found.

While operating on a patient with chronic uveitis presents some challenges, there are a few pearls that may increase success.

Study of subjects with rare inherited form of AD shows increased retinal capillary perfusion during the presymptomatic stage.

As the Fourth of July approaches, ophthalmologists warn patients to exercise caution with fireworks.

Deep learning predictions of the retinal nerve fiber layer thickness based solely on fundus photographs can be used to monitor the risk of future glaucomatous conversion in glaucoma suspects.

A survey of fireworks-related injuries for ophthalmologists and retina specialists.

Clues to diagnosis from patient and family histories, examination techniques.

If approved, PDS ranibizumab would become the first and only eye implant with continuous drug delivery, offering an alternative to more frequent anti-VEGF injections for people with wet AMD.

In a study, a single intravitreal injection of ADVM-022 had a 99% reduction in the mean annualized frequency of anti-VEGF injections.

Investigators corroborate the hypothesis that retinal ganglion cells with dendrites stratified in the off sublaminae could be damaged.

In endophthalmitis, the systemic anti-infective treatment specific to the infectious agent should always be used.

According to investigators, the new technology is designed to detect telltale signs of major blinding diseases in retinal blood and tissue that typically go unseen until it is too late.

Amid pandemic, physicians and patients have embraced remote technology.

Measures of inflammation can predict treatment outcomes for patients

An updated PDS procedure reduces complications.

Standardization of Uveitis Nomenclature (SUN) Working Group utilized machine learning to create new uveitis classification criteria, inciting hope for implementation in clinical and research settings.

The not-for-profit vision and healthcare organization breaks ground on premier Technology Center for assistive technology for people with vision loss.

PDUFA action date of October 30, 2021, is assigned for investigational therapy with a proposed indication of treatment of macular edema associated with uveitis.

Retinal imaging tests are providing material to train and test decision support systems.

RGX-314 eyed by investigators as a therapeutic option for exudative AMD.

An international research team has shown that optogenetic therapy has helped to partially regain visual function in a patient with retinitis pigmentosa. This is a milestone towards a gene therapy that could restore vision.

Preexisting neutralizing antibodies associated with the inflammatory changes.

Novel therapies are shifting the paradigm in care of retinal diseases